The Blood Brain Barrier (BBB)

Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuitio

  • PDF / 3,487,269 Bytes
  • 169 Pages / 439.43 x 683.15 pts Page_size
  • 24 Downloads / 173 Views

DOWNLOAD

REPORT


Gert Fricker Melanie Ott Anne Mahringer  Editors

The Blood Brain Barrier (BBB)

10

Topics in Medicinal Chemistry

Editorial Board: P. R. Bernstein, Rose Valley, USA A. Buschauer, Regensburg, Germany G. I. Georg, Minneapolis, USA J. A. Lowe, Stonington, USA U. Stilz, Malov, Denmark C. T. Supuran, Sesto Fiorentino (Firenze), Italy A. K. Saxena, Lucknow, India

Aims and Scope Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine. Therefore, the new topic-related series Topics in Medicinal Chemistry will cover all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drugability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known guest editors. In references Topics in Medicinal Chemistry is abbreviated Top Med Chem and is cited as a journal.

More information about this series at http://www.springer.com/series/7355

Gert Fricker Melanie Ott Anne Mahringer l

l

Editors

The Blood Brain Barrier (BBB)

With contributions by D. Belletti  R. Chhabra  R. van Doorn  D. Ferna´ndezLo´pez  F. Forni  G. Fricker  A.M. Grabrucker  M. Hammarlund-Udenaes  A. Mahringer  S. Meairs  D.S. Miller  M.R. Mizee  M. Ott  A. Prat  B. Ruozi  G. Tosi  M.A. Vandelli  Z.S. Vexler  H.E. de Vries

Editors Gert Fricker Institut fu¨r Pharmazie und Molekulare Biotechnologie Universita¨t Heidelberg Heidelberg Baden-Wu¨rttemberg Germany

Melanie Ott Anne Mahringer Dept. for Pharmaceutical Technology and Pharmacology Institute of Pharmacy and Molecular Biotechnology Heidelberg Germany

ISSN 1862-2461 ISSN 1862-247X (electronic) ISBN 978-3-662-43786-5 ISBN 978-3-662-43787-2 (eBook) DOI 10.1007/978-3-662-43787-2 Springer Heidelberg New York Dordrecht London Library of Congress Control Number: 2014947829 # Springer-Verlag Berlin Heidelberg 2014 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifically for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Duplication of this publication or parts thereof